T1	Outcomes 27 59	distant metastasis and mortality
T2	Outcomes 757 787	tumor nuclei staining positive
T3	Outcomes 848 885	per-sample mean intensity score (MIS)
T4	Outcomes 964 986	overall mortality (OM)
T5	Outcomes 1054 1113	distant metastasis (DM) and cause-specific mortality (CSM).
T6	Outcomes 1203 1222	MDM2 overexpression
T7	Outcomes 1252 1254	DM
T8	Outcomes 1288 1308	Ki-67 overexpression
T9	Outcomes 1338 1340	DM
T10	Outcomes 1354 1357	CSM
T11	Outcomes 1375 1377	OM
T12	Outcomes 1389 1407	P53 overexpression
T13	Outcomes 1437 1439	OM
T14	Outcomes 1487 1524	overexpression of both Ki-67 and MDM2
T15	Outcomes 1560 1597	significantly increased failure rates
T16	Outcomes 1669 1701	MDM2 and Ki-67 expression levels
T17	Outcomes 1732 1764	distant metastasis and mortality
